Supriya Lifescience Limited (SUPRIYA) — Strategic Asset Allocation Index
Supriya Lifescience Limited (SUPRIYA) has a Strategic Asset Allocation Index of 46.9% as of March 2023. Strategic assets (PP&E of Rs3.28 Billion plus long-term investments of Rs-) total Rs3.28 Billion, measured against net assets of Rs6.99 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Supriya Lifescience Limited Strategic Asset Allocation Index (2018–2022)
This chart shows how Supriya Lifescience Limited's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of March 2023, the index stands at 46.9%, representing strategic assets of Rs3.28 Billion against net assets of Rs6.99 Billion INR. Explore Supriya Lifescience Limited operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Supriya Lifescience Limited (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Supriya Lifescience Limited from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Supriya Lifescience Limited.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 37.6% | Rs2.32 Billion | Rs2.32 Billion | Rs- | Rs6.16 Billion | ▼ -28.3 pp |
| 2021 | 65.9% | Rs1.77 Billion | Rs1.77 Billion | Rs- | Rs2.69 Billion | ▼ -24.6 pp |
| 2020 | 90.5% | Rs1.35 Billion | Rs1.35 Billion | Rs- | Rs1.49 Billion | ▼ -35.4 pp |
| 2019 | 125.9% | Rs1.18 Billion | Rs1.18 Billion | Rs- | Rs937.91 Million | ▼ -102.6 pp |
| 2018 | 228.5% | Rs1.25 Billion | Rs1.25 Billion | Rs- | Rs546.57 Million | — |